CE Instructions for
WB4639: Novavax COVID-19 Vaccine: What Healthcare Professionals Need to Know
(Credit expires 8/29/2024)

To receive continuing education (CE)
In order to receive continuing education (CE) for WB4639 Novavax COVID-19 Vaccine: What Healthcare Professionals Need to Know, please visit TCEO at www.cdc.gov/getCE  and follow the 9 Simple Steps by 8/29/2024. 
NOTE—You must pass the posttest at 80%. There are only 2 attempts allowed.

If you have any questions or problems, contact CDC/ATSDR Training and Continuing Education Online via email at ce@cdc.gov. You may also contact the CE Coordinator at NCIRD, Melissa Barnett at MBarnett2@cdc.gov

PROGRAM DESCRIPTION: CDC has created a new, web-on-demand, self-paced module for healthcare providers who will be administering Novavax COVID-19 Vaccine. This module will provide information to healthcare professionals about COVID-19 vaccine based on the recommendations of the Advisory Committee on Immunization Practices and guidance from the manufacturer.

OBJECTIVES: At the conclusion of the session, the participant will be able to:
Describe characteristics of the  Novavax COVID-19 vaccine used to prevent COVID-19 disease.
Describe storage and handling requirements for Novavax COVID-19 vaccine.
Describe vaccine preparation procedures for Novavax COVID-19 vaccine.
Describe vaccine administration procedures for Novavax COVID-19 vaccine.
Locate current immunization resources to increase knowledge of team’s role in program implementation for improved team performance.
Implement disease detection and prevention health care services (e.g., smoking cessation, weight reduction, diabetes screening, blood pressure screening, immunization services) to prevent health problems and maintain health.

Lauren Hughes, MPH, Health Communications Specialist, CDC, NCIRD
Andrew Kroger,  MD, MPH, Medical Officer, CDC/NCIRD
Sarah L Morales, MPH, MBA, CHES, Health Educator, Goldbelt C6, LLC

ORIGINATION DATE: 08/29/2022                                                                                                   EXPIRATION DATE: 08/29/2024

URL: https://www2.cdc.gov/vaccines/ed/covid19/Novavax/index.asp  

HARDWARE/SOFTWARE: Computer Hardware; Internet connection; Browser; MATERIALS: Internet connection and computer

TARGET AUDIENCE: Administrators, CHES certified health educators, Physicians, Epidemiologists, LPNs, LVNs, Medical assistants, medical students, NPs, nurse technicians, other health educators, Pharmacists, PAs, program managers RNs

PREREQUISITES: Participants should have a basic educational background in science including general knowledge in the subject areas of biology, immunization, and vaccine-preventable diseases.

FORMAT: This course is Enduring material.

CE Logo In support of improving patient care, The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME:  The Centers for Disease Control and Prevention designates this Enduring activity for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA CME:  The Centers for Disease Control and Prevention has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for .5 AAPA Category 1 CME credits. Approval is valid until 3/5/2023. PAs should only claim credit commensurate with the extent of their participation.

CNE:  The Centers for Disease Control and Prevention designates this activity for .5 nursing contact hours.

CPE: The Centers for Disease Control and Prevention designated this knowledge-based event for pharmacists to receive .05 CEUs (.5 contact hours) in pharmacy education. The Universal Activity Number is JA4008229-0000-22-124-H06-P.

Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline.  Official credit will be uploaded within 60 days on the NABP/CPE Monitor.

CEU:  The Centers for Disease Control and Prevention is authorized by IACET to offer .1 CEU's for this program.

CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to .5 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are .5. Continuing Competency credits available are .5. CDC provider number 98614.

DISCLOSURE: In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies during the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.  

CDC, our planners, and content experts, wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept financial or in-kind support from any ineligible company for this continuing education activity.

FEES: No fees are charged for CDC’s CE activities.